JP2004510749A5 - - Google Patents

Download PDF

Info

Publication number
JP2004510749A5
JP2004510749A5 JP2002532257A JP2002532257A JP2004510749A5 JP 2004510749 A5 JP2004510749 A5 JP 2004510749A5 JP 2002532257 A JP2002532257 A JP 2002532257A JP 2002532257 A JP2002532257 A JP 2002532257A JP 2004510749 A5 JP2004510749 A5 JP 2004510749A5
Authority
JP
Japan
Prior art keywords
agonist
ppardelta
activator
ppar delta
synthase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002532257A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004510749A (ja
Filing date
Publication date
Priority claimed from GBGB0024362.6A external-priority patent/GB0024362D0/en
Application filed filed Critical
Publication of JP2004510749A publication Critical patent/JP2004510749A/ja
Publication of JP2004510749A5 publication Critical patent/JP2004510749A5/ja
Pending legal-status Critical Current

Links

JP2002532257A 2000-10-05 2001-10-02 No阻害またはtnf阻害に関連した疾病の治療におけるpparデルタ活性化因子の使用 Pending JP2004510749A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0024362.6A GB0024362D0 (en) 2000-10-05 2000-10-05 Medicaments
PCT/GB2001/004370 WO2002028433A2 (en) 2000-10-05 2001-10-02 Use of a ppar delta activator in the treatment of diseases related to no inhibit ion or tnf inhibition

Publications (2)

Publication Number Publication Date
JP2004510749A JP2004510749A (ja) 2004-04-08
JP2004510749A5 true JP2004510749A5 (enExample) 2005-12-22

Family

ID=9900710

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002532257A Pending JP2004510749A (ja) 2000-10-05 2001-10-02 No阻害またはtnf阻害に関連した疾病の治療におけるpparデルタ活性化因子の使用

Country Status (6)

Country Link
US (1) US20040029938A1 (enExample)
EP (1) EP1324773A2 (enExample)
JP (1) JP2004510749A (enExample)
AU (1) AU2001292044A1 (enExample)
GB (1) GB0024362D0 (enExample)
WO (1) WO2002028433A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL160845A0 (en) 2001-09-14 2004-08-31 Tularik Inc Linked biaryl compounds
WO2004093910A1 (ja) * 2003-04-22 2004-11-04 Astellas Pharma Inc. PPARδアゴニストによる脳神経変性疾患治療剤
PT1638963E (pt) * 2003-05-20 2009-11-18 Novartis Ag Heterociclos de azoto n-acilado como ligandos de receptores activados pelo proliferador peroxissomal
JP2006527175A (ja) * 2003-06-06 2006-11-30 エフ.ホフマン−ラ ロシュ アーゲー アニリン誘導体
CA2530452C (en) 2003-07-02 2011-07-26 F. Hoffmann-La Roche Ag Indolyl derivatives substituted with a thiazole ring and their use as ppar modulators
JP2007530703A (ja) * 2004-04-01 2007-11-01 アベンティス・ファーマスーティカルズ・インコーポレイテツド Msおよびその他の脱髄疾患を治療するためのペルオキシソーム増殖因子活性化受容体デルタアゴニストの使用
US7126825B2 (en) * 2004-12-07 2006-10-24 Cleavage Enterprise Co., Ltd. Combined chip/heat-dissipating metal plate and method for manufacturing the same
EP2464349A2 (en) * 2009-08-14 2012-06-20 Cerenis Therapeutics S.A. Use of ppar delta ligands for the treatment or prevention of inflammation or energy metabolism/production related diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997028149A1 (en) * 1996-02-02 1997-08-07 Merck & Co., Inc. Method for raising hdl cholesterol levels
US6300364B1 (en) * 1997-07-24 2001-10-09 Yamanouchi Pharmaceutical Co., Ltd. Medicinal compositions with cholesterol-lowering effect
GB9914977D0 (en) * 1999-06-25 1999-08-25 Glaxo Group Ltd Chemical compounds
EP1170008A1 (en) * 2000-07-07 2002-01-09 Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus Valproic acid and derivatives thereof as histone deacetylase inhibitors

Similar Documents

Publication Publication Date Title
JP2004510750A5 (enExample)
JP2004505105A5 (enExample)
JP2002543065A5 (enExample)
JP2006526590A5 (enExample)
JP2005511547A5 (enExample)
JP2004516314A5 (enExample)
JP2008543854A5 (enExample)
JP2004535466A5 (enExample)
JP2009541387A5 (enExample)
JP2005527576A5 (enExample)
JP2008519847A5 (enExample)
JP2004510749A5 (enExample)
JP2007502817A5 (enExample)
JP2008524127A5 (enExample)
CN1210027C (zh) 治疗溃疡的药物组合物及其应用
JP2005517677A5 (enExample)
JP2006524252A5 (enExample)
JP2023022236A5 (enExample)
CN1382128A (zh) 取代的苄基噻唑烷-2,4-二酮衍生物
JP2004502684A5 (enExample)
JP2004532828A5 (enExample)
JP2008520662A5 (enExample)
JP2004538314A5 (enExample)
JP2011508779A5 (enExample)
JP2007506664A5 (enExample)